InSeal Vascular Closure Device Clinical Study Protocol — VCD  

Percutaneous Closure of Artery Access Sites Clinical Trial

Official title: InSeal Vascular Closure Device Clinical Study Protocol

Status Terminated

Clinical Trial Summary

The InSeal vascular closure device (VCD)is assessed as percutaneous closure of artery access sites for quick hemostasis and ambulation in patients who have undergone large bore endovascular catheterization procedures.

The study hypothesis is that the VCD is safe and efficaient in achieving hemostasis in the study population.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Percutaneous Closure of Artery Access Sites

• NCT number: NCT01896401
• Study type: Interventional
• Source: InSeal Medical Ltd.
• Status: Terminated
• Phase: N/A
• Start date: February 2012
• Completion date: August 2015